Validus Holdings, Ltd. (NYSE:VR) President Kean Driscoll sold 6,875 shares of the company’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $46.78, for a total transaction of $321,612.50. Following the sale, the president now owns 103,983 shares of the company’s stock, valued at $4,864,324.74. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Kean Driscoll also recently made the following trade(s):

  • On Friday, December 15th, Kean Driscoll sold 6,875 shares of Validus stock. The shares were sold at an average price of $46.16, for a total transaction of $317,350.00.
  • On Wednesday, November 15th, Kean Driscoll sold 6,875 shares of Validus stock. The shares were sold at an average price of $50.30, for a total transaction of $345,812.50.

Validus Holdings, Ltd. (NYSE:VR) opened at $47.28 on Thursday. The company has a current ratio of 0.95, a quick ratio of 0.95 and a debt-to-equity ratio of 0.52. The stock has a market cap of $3,720.40, a price-to-earnings ratio of -72.74, a price-to-earnings-growth ratio of 1.26 and a beta of 0.67. Validus Holdings, Ltd. has a 1 year low of $41.15 and a 1 year high of $58.76.

Validus (NYSE:VR) last released its earnings results on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($3.30) by $0.08. The firm had revenue of $407.00 million for the quarter, compared to the consensus estimate of $453.04 million. Validus had a negative net margin of 1.38% and a negative return on equity of 0.49%. The company’s revenue was up 24.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.02 EPS. equities research analysts predict that Validus Holdings, Ltd. will post -0.3 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 29th. Stockholders of record on Friday, December 15th were given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a dividend yield of 3.21%. The ex-dividend date of this dividend was Thursday, December 14th. Validus’s dividend payout ratio is presently -233.84%.

A number of research analysts have issued reports on VR shares. Keefe, Bruyette & Woods reissued a “hold” rating and set a $51.00 price objective on shares of Validus in a research report on Thursday, October 12th. UBS Group boosted their price objective on shares of Validus from $48.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday, October 30th. Bank of America raised shares of Validus from a “neutral” rating to a “buy” rating in a research report on Monday, October 30th. ValuEngine downgraded shares of Validus from a “buy” rating to a “hold” rating in a research report on Wednesday, October 11th. Finally, Zacks Investment Research reissued a “strong sell” rating on shares of Validus in a research report on Saturday, January 6th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $54.33.

Several large investors have recently added to or reduced their stakes in VR. SG Americas Securities LLC purchased a new stake in shares of Validus in the 2nd quarter worth about $116,000. Bank of New York Mellon Corp grew its position in shares of Validus by 1.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 307,542 shares of the insurance provider’s stock worth $15,982,000 after buying an additional 5,878 shares during the period. BNP Paribas Arbitrage SA grew its position in shares of Validus by 93.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock worth $138,000 after buying an additional 1,282 shares during the period. Neuberger Berman Group LLC grew its position in shares of Validus by 26.6% in the 2nd quarter. Neuberger Berman Group LLC now owns 7,731 shares of the insurance provider’s stock worth $402,000 after buying an additional 1,626 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Validus by 10.6% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,905 shares of the insurance provider’s stock worth $151,000 after buying an additional 278 shares during the period. 96.25% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Kean Driscoll Sells 6,875 Shares of Validus Holdings, Ltd. (VR) Stock” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2018/01/18/kean-driscoll-sells-6875-shares-of-validus-holdings-ltd-vr-stock.html.

Validus Company Profile

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Insider Buying and Selling by Quarter for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.